ML-7 amplifies the quinocetone-induced cell death through akt and MAPK-mediated apoptosis on HepG2 cell line

Toxicology Mechanisms and Methods

Volumn 26, Issue 1, 2016, Pages 11-21

  Zhou, Yan ^a   Zhang, Shen ^a   Deng, Sijun ^a   Dai, Chongshan ^a   Tang, Shusheng ^a   Yang, Xiayun ^a   Li, Daowen ^a   Zhao, Kena ^a   Xiao, Xilong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Akt; apoptosis; HepG2; MAPK; ML 7; quinocetone

Indexed keywords

1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; CASPASE 3; CASPASE 8; CASPASE 9; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; QUINOCETONE; QUINOXALINE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; AZEPINE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NAPHTHALENE DERIVATIVE; QUINOXALINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; CELL SURVIVAL; CHEMISTRY; COMBINATION DRUG THERAPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; METABOLISM;

APOPTOSIS; AZEPINES; CELL SURVIVAL; DRUG THERAPY, COMBINATION; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NAPHTHALENES; PROTO-ONCOGENE PROTEINS C-AKT; QUINOXALINES;

EID: 84945218334     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2015.1090513     Document Type: Article

References (51)

1. Altomare DA, Testa JR. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-64
2. Bai L, Wang S. (2014). Targeting apoptosis pathways for new cancer therapeutics. Annu Rev Med 65: 139-55
3. Bradham C, McClay DR. (2006). p38 MAPK in development and cancer. Cell Cycle 5: 824-8
4. Burotto M, Chiou VL, Lee JM, Kohn EC. (2014). The MAPK pathway across different malignancies: a new perspective. Cancer 120: 3446-56
5. Chang F, Lee JT, Navolanic PM, et al. (2003). Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603
6. Chen Q, Tang S, Jin X, et al. (2009). Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem Toxicol 47: 328-34
7. Cui WJ, Liu Y, Zhou XL, et al. (2010). Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway. Acta Pharmacol Sin 31: 725-32
8. Dent P, Yacoub A, Fisher PB, et al. (2003). MAPK pathways in radiation responses. Oncogene 22: 5885-96
9. Eferl R, Ricci R, Kenner L, et al. (2003). Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112: 181-92
10. Fazal F, Gu L, Ihnatovych I, et al. (2005). Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol 25: 6259-66
11. Fenteany G, Zhu ST. (2003). Small-molecule inhibitors of actin dynamics and cell motility. Curr Topics Med Chem 3: 593-616
12. Fesik SW. (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5: 876-85
13. Franke TF, Hornik CP, Segev L, et al. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-98
14. Gourlay CW, Ayscough KR. (2006). Actin-induced hyperactivation of the Ras signaling pathway leads to apoptosis in Saccharomyces cerevisiae. Mol Cell Biol 26: 6487-501
15. Gu LZ, Hu WY, Antic N, et al. (2006). Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer 42: 948-57
16. Hay N. (2005). The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-83
17. Hennessy BT, Smith DL, Ram PT, et al. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004
18. Huang XL, Cui GH, Zhou KY. (2008). Correlation of PI3K-Akt signal pathway to apoptosis of tumor cells. Chinese J Cancer 27: 331-6
19. Ihsan A, Wang X, Zhang W, et al. (2013). Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem Toxicol 59: 207-14
20. Jana SS, Kawamoto S, Adelstein RS. (2006). A specific isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell line. J Biol Chem 281: 24662-70
21. Jin X, Chen Q, Tang SS, et al. (2009). Investigation of quinocetone-induced genotoxicity in HepG2 cells using the comet assay, cytokinesis-block micronucleus test and RAPD analysis. Toxicol In Vitro 23: 1209-14
22. Jordan MA, Wilson L. (1998). Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr Opin Cell Biol 10: 123-30
23. Jordan MA, Wilson L. (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-65
24. Kataoka K, Matsumoto H, Kaneko H, et al. (2015). Macrophage-and RIP3-dependent inflammasome activation exacerbates retinal detachment-induced photoreceptor cell death. Cell Death Dis 6: e1731
25. Knasmuller S, Mersch-Sundermann V, Kevekordes S, et al. (2004). Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology 198: 315-28
26. Knauf JA, Fagin JA. (2009). Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Curr Opin Cell Biol 21: 296-303
27. Kondratskyi A, Yassine M, Slomianny C, et al. (2014). Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death. Cell Death Dis 5: e1193
28. Lee JW, Ha TK, Woo HD, Chung HW. (2009). Cytotoxic effects of myosin light chain kinase inhibitor Ml-7 alone and in combination with flavonoid against Hl-60. Ann Oncol 20: 33
29. Li Q, Chen M, Liu HM, et al. (2014). The dual role of ERK signaling in the apoptosis of neurons. Front Biosci 19: 1411-17
30. Llovet JM, Burroughs A, Bruix J. (2003). Hepatocellular carcinoma. Lancet 362: 1907-17
31. Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261-74
32. New DC, Wu K, Kwok AWS, Wong YH. (2007). G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis. FEBS J 274: 6025-36
33. Rane MJ, Klein JB. (2009). Regulation of neutrophil apoptosis by modulation of PKB/Akt activation. Front Biosci 14: 2400-12
34. Roux PP, Blenis J. (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-44
35. Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, Pavasant P. (2008). TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem Biophys Res Commun 371: 713-18
36. Strasser A, OConnor L, Dixit VM. (2000). Apoptosis signaling. Annu Rev Biochem 69: 217-45
37. Sui X, Kong N, Ye L, et al. (2014). p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 344: 174-9
38. Vivanco I, Sawyers CL. (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501
39. Wada T, Penninger JM. (2004). Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-49
40. Wagner EF, Nebreda AR. (2009). Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537-49
41. Wang D, Zhong Y, Luo XA, et al. (2011). Pu-erh black tea supplementation decreases quinocetone-induced ROS generation and oxidative DNA damage in Balb/c mice. Food Chem Toxicol 49: 477-84
42. Wang X, Zhang W, Wang YL, et al. (2010). Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats. Regul Toxicol Pharmacol 58: 421-7
43. Watanabe T, Nakagawa K, Ohata S, et al. (2002). SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol 250: 332-47
44. Yang W, Fu J, Xiao X, et al. (2013). Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders. J Sci Food Agric 93: 1317-25
45. Yu M, Wang D, Xu M, et al. (2014). Quinocetone-induced Nrf2/HO-1 pathway suppression aggravates hepatocyte damage of Sprague-Dawley rats. Food Chem Toxicol 69: 210-19
46. Yu M, Xu M, Liu Y, et al. (2013). Nrf2/ARE is the potential pathway to protect Sprague-Dawley rats against oxidative stress induced by quinocetone. Regul Toxicol Pharmacol 66: 279-85
47. Zhang C, Wang C, Tang S, et al. (2013). TNFR1/TNF-α and mitochondria interrelated signaling pathway mediates quinocetone-induced apoptosis in HepG2 cell. Food Chem Toxicol 62: 825-38
48. Zhang W, Liu HT. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12: 9-18
49. Zhang XB, Tang NM, Hadden TJ, Rishi AK. (2011). Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813: 1978-86
50. Zhong JL, Zhang GJ, Shen XG, et al. (2011). Pharmacokinetics of quinocetone and its major metabolites in swine after intravenous and oral administration. Agric Sci China 10: 1292-300
51. Zhou XL, Liu Y, You JC, et al. (2008). Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 270: 312-27